AESKUCARE® Gluten-Related Disorders IgA is a nearpatient (point of care) in-vitro immunoassay intended for the qualitative and quantitative simultaneous measurement of human-specific IgA antibodies against tTG, tTG neo, mTG, mTG neo, DGP, gliadin, Frazer’s fraction, TG3, and total IgA in heparinized or Na-EDTA venous or capillary whole blood, plasma, or serum. sIgA concentrations can be determined quantitatively by using a separately available reader or qualitatively by the naked eye.
Test kit includes all necessary equipment (test device, blood sampling kit, test reagents, etc.)
Hygienic – blood sample and reagents are retained within the device
Suitable for both, adults and children
Aimed at enabling diagnostics and saving time for health practitioners, diagnostic laboratories, nutritionists, dieticians and patients
Healthcare practitioners and nutritionists can test their patients during consultation, no waiting for laboratory test results
18 months shelf life
Intended Use:
It is intended for use as a point of care tool to support the diagnosis of patients presenting with various clinical symptoms associated with gluten-related disorders. It is to be carried out by healthcare professionals experienced in the use of in vitro diagnostic methods.
Coated Antigens:
mTG neo (test row 2)
Microbial transglutaminase (neo-epitopes)
TG3 (test row 2)
Transglutaminase 3 (human epidermal transglutaminase)
tTG (test row 2)
Human tissue transglutaminase
tTG neo (test row 2)
Human tissue transglutaminase (neo-epitopes)
mTG (test row 3)
Microbial transglutaminase
Frazer`s F (test row 3)
Frazer´s fraction